GO
Loading...

Teva Pharmaceutical Industries Ltd

More

  • Worst First Half Since '02 Monday, 30 Jun 2008 | 5:44 PM ET

    After hours Morgan Stanley recommended investors buy Lehman Brothers stock and set a price target of $31. What's the "Word on the Street?"

  • A Hurry-Up Offense for the Second Half Monday, 30 Jun 2008 | 1:24 PM ET

    It was an ugly first half for the stock market and now that the goal posts have been moved for the economic recovery, expect a rough game in the second half.

  • Dow Falls Below 12,000 Friday, 20 Jun 2008 | 5:53 PM ET

    The Dow closed sharply lower Friday, registering its third triple-digit loss in four sessions. What's the "Word on the Street?"

  • Lightning Round OT: Visa, Mercadolibre and More Thursday, 19 Jun 2008 | 7:01 PM ET

    The Lightning Round is extended in this CNBC.com exclusive feature.

  • Medical Breakthrough Boom Tuesday, 17 Jun 2008 | 6:11 PM ET

    On Tuesday we received word of three exciting medical advancements. Find out what’s happening and how to trade them.

  • Pops & Drops: Marvel, Disney... Tuesday, 10 Jun 2008 | 6:37 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of Marvel and Disney popped while Garmin and BHP Billiton dropped.

  • Ormat's Core Business Thursday, 8 May 2008 | 6:21 PM ET

    This geothermal energy play has plenty of room to grow.

  • The Pros' Picks Wednesday, 7 May 2008 | 1:20 PM ET

    As the Dow, Nasdaq and S&P slide into negative territory, CNBC asked the experts how to bolster your investments.

  • Little-Known Investing Gems Wednesday, 7 May 2008 | 12:28 PM ET

    Haim Israel of Merrill Lynch in Jerusalem has some ideas about smaller Israeli companies that might have escaped the attention of U.S. investors.

  • Israel at 60: Investing in Israel Wednesday, 7 May 2008 | 6:58 AM ET

    When Apple's Steve Job's picked Israeli Yael Naim's "New Soul" for the Mac Air commercial, it wasn't the first time Silicon Valley connected with Israel.  In fact, Israel has more companies traded on the tech heavy Nasdaq than any other country outside the United States.  As Israel celebrates its 60th anniversary of statehood, here are some more facts and figures on the Israeli economy and markets...

  • AstraZeneca Shares Leap on Nexium Settlement Deal Tuesday, 15 Apr 2008 | 5:50 AM ET

    AstraZeneca has settled U.S. patent litigation against India's Ranbaxy Laboratories over its top-selling drug, ulcer pill Nexium, securing future sales and sending its shares soaring.

  • 5-Star Manager:  Look Overseas Wednesday, 19 Mar 2008 | 12:29 PM ET

    All the excitement in the United States this week may have distracted investors from the global investment scene.  Five-star fund co-manager Wendy Trevisani suggests that would be a mistake, and she has some prominent international names to prove it.

  • The Return of Big Pharma Friday, 14 Mar 2008 | 6:44 PM ET

    This could be the sector to own by next fall's presidential election.

  • The 'Nifty 50': Rebound Stocks (Pt.3) Wednesday, 13 Feb 2008 | 2:04 PM ET

    When the economy rebounds, where's your portfolio going to be? UBS says that's a question to answer right now. The bank released what it calls its "'New' Nifty Fifty," a list of 50 companies from around the world that can use today's troubling market conditions to position themselves to thrive when the economy rebounds. (PART 3)

  • Sudden Death: Puget Energy, Teva Pharma and More Tuesday, 15 Jan 2008 | 8:29 PM ET

    It's a booyah-free zone. There goes Swifty!Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • My 7 For '07: The Pharma Year in Review Friday, 28 Dec 2007 | 1:57 PM ET

    The seven biggest stories in my sectors in 2007? Avandia, Dendreon, Pfizer, Biogen were just a few of the topics that made this a fascinating year for the pharmaceuticals and biotechnology industries.

  • Wyeth: More Heartburn From Copycats? Wednesday, 26 Dec 2007 | 11:41 AM ET

    Shares of drugmaker Wyeth could remain under pressure this day after Christmas. At least two analysts are suggesting that Wyeth could be under assault by another generic drug company.

  • Holiday Cheer Sees Stocks End Higher Monday, 24 Dec 2007 | 1:45 PM ET

    Christmas Eve brought glad tidings to Wall Street, with holiday cheer emanating from the battered financial sector and spreading through the market.

  • Wyeth Sues Teva over Heartburn Drug Patent Monday, 24 Dec 2007 | 7:36 AM ET

    Wyeth said Monday it will sue Teva Pharmaceuticals USA for alleged patent infringement and said it received an approvable letter from U.S regulators for bazedoxifene, a drug that helps prevent post-menopausal osteoporosis.

  • Crazy Finish But Comeback Continues Thursday, 9 Aug 2007 | 10:48 AM ET

    Wednesday was a crazy day for the markets, but when all was said and done The Dow finished 150 points higher and Blackstone (BX) formed the largest buyout fund ever. Is a steady comeback building this week for stocks? Here's the word on The Street.